FDA gives COVID drug with Memphis ties fast-track to emergency use
The drug was created as an anti-cancer agent in collaboration with GTx, a former Memphis pharmaceutical firm.
Topics
sabizabulin Veru Inc Mitchell Steiner coronavirus COVID-19 GTx ARDSJane Roberts
Longtime journalist Jane Roberts is a Minnesotan by birth and a Memphian by choice. She's lived and reported in the city more than two decades. She covers business news and features for The Daily Memphian.
Want to comment on our stories or respond to others? Join the conversation by subscribing now. Only paid subscribers can add their thoughts or upvote/downvote comments. Our commenting policy can be viewed here.